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INTRODUCTION
A number of injectable materials have popularly been used
to treat soft tissue defects, although fat injections or grafts are
most popular. Micronized acellular dermal matrix (Alloderm),
an injectable material, is a highly versatile intermediate-length
implant with many applications. However, though cell in-
growths and revascularization of implanted micronized Allo-
derm are an important factor for lasting the length of results,
this process unfortunately does not appear to occur in every-
one (1). To improve results after injecting micronized Allo-
derm, the authors admixed micronized Alloderm with adi-
pose stem cells (ASCs). ASCs have been used in adipose tis-
sue engineering (2, 3), because ASCs, harvested sufficiently
from adipose tissue, are known to possess the ability of high
proliferation and strong differentiation to adipocytes (4) and
endothelial cells (5). The authors considered that adipocytes
differentiated from ASCs in micronized Alloderm would
make the injected micronized Alloderm a more acceptable
soft tissue substitute, and the differentiated endothelial cells
would enhance implantation of the injected soft tissue con-
structs. 
To develop an injectable soft tissue filler, the authors tried
to produce adipose tissue equivalents using ASCs and micro-
nized Alloderm as scaffold by introducing the concept of
tissue engineering. 
MATERIALS AND METHODS
Isolation and multiplication of human ASCs 
Human ASCs were isolated from adipose tissue obtained by
abdominoplasty via enzymatic digestion. Briefly, after remov-
ing visible fibrous tissue and vessels, adipose tissue was fine-
ly minced and enzymatically digested in dulbeccos modified
eagles medium (DMEM)/F-12 media (Gibco, Gaithersburg,
MD, U.S.A.) containing 0.1% type I collagenase (Sigma
Chemical Co., St. Louis, MO, U.S.A.), 1% fatty acid free
bovine serum albumin (Sigma), and 1× Penicillin-Strepto-
mycin (Gibco) for 30 min at 37℃ at adipose tissue to a dis-
sociation medium ratio of 2 g/1 mL. The digested tissue was
filtered through cotton gauze, and the filtrate suspension
was centrifuged at 1,000 rpm for 5 min, cell pellet were then
resuspended in DMEM/F-12 media (Gibco) supplemented
with 10% bovine calf serum (Hyclone, Logan, UT, U.S.A.)
and 1× penicillin-streptomycin (Sigma). ASCs were plated
at 104 cells/mL and passaged two or three times. 
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Tissue Engineering of Injectable Soft tissue Filler: Using Adipose
Stem Cells and Micronized Acellular Dermal Matrix
In this study of a developed soft tissue filler, adipose tissue equivalents were con-
structed using adipose stem cells (ASCs) and micronized acellular dermal matrix
(Alloderm). After labeling cultured human ASCs with fluorescent green protein and
attaching them to micronized Alloderm (5× ×10
5 cells/1 mg), ASC-Alloderm complex-
es were cultured in adipogenic differentiation media for 14 days and then injected
into the dorsal cranial region of nude male mice. The viabilities of ASCs in micronized
Alloderm were determined at 1, 4, 7, and 14 days, and complexes, which had been
cultured for 14 days and implanted in vivo for 2 months, were histologically evaluated
by light, confocal, and scanning electron microscopy. The viabilities represented
that ASCs in micronized Alloderm were alive during the culture period. ASC-Allo-
derm complexes cultured for 14 days contained round cells with large lipid vesicles
by light microscopy and many spherical cells by SEM. ASCs in implanted ASC-
Alloderm complexes harvested from mice at 2 months postinjection were histologi-
cally found to have differentiated into adipocytes which had green fluorescence
dye. Micronized Alloderm may be found useful as scaffold for human ASCs when
constructing fat tissue for three-dimensional soft tissue filling. The present study
suggests that ASC-Alloderm complexes can be used as injectable three-dimen-
sional soft tissue fillers. 
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Labeling and the induction of differentiation of human
ASCs
PKH67 green fluorescent cell linker kits (Sigma) were
used for labeling ASCs. Briefly, ASCs were trypsinized and
washed once with DMEM/F-12 medium without serum. 2
×107 cells suspended in medium were placed in 15 mL cen-
trifuge tubes, and centrifuged (400× g) for 5 min to form
loose pellets. Medium was then carefully aspirated to leave
no more than 25 μ L of residual medium on pellets. The cells
were then resuspended in this residual medium, and 1 mL
of Diluent C was added. Immediately prior to staining, a 2×
staining solution of PKH67 was prepared in polypropylene
tube by diluting 4 μ L of 1 mM dye stock in 1 mL of Dilu-
ent C. Staining was initiated by rapidly adding a 2× con-
centrated cell suspension to the 2× dye solution. Staining
was stopped after 5 min by adding an equal volume (2 mL)
of fetal bovine serum over a period of 1 min followed by an
equal volume (4 mL) of complete medium containing 10%
serum. Cells were then centrifuged and washed three times
with 10 mL of complete medium. Stained cells were cultured
as monolayers in adipogenic differentiation media (Zen-Bio
Co, Research Triangle, NC, U.S.A.) for 14 days. ASCs cul-
tured in adipogenic differentiation media were visualized
and photographed under an inverted microscope (Axiovert
200 M, Zeiss, Gottingen, Germany) equipped with a color
digital camera. A fluorescein isothiocyanate fluorescent fil-
ter set was used to visualize labeled cells.
In vitro culture and the induction of differentiation of ASC-
Alloderm complex
Micronized acellular dermal matrix (micronized Alloderm)
was purchased from ShebaTM (Hans Biomed Co., Seoul, Korea).
Briefly, micronized Alloderm in a syringe was hydrated with
6 mL of DMEM/F-12 media (Gibco) for 30 min, and cen-
trifuged at 1,000 rpm for 5 min. Supernatant was aspirated
off, and 3mL media was added. 
ASC-Alloderm complexes were made by mixing human
ASCs and micronized Alloderm at 5×104 cells/mg of mic-
ronized Alloderm. After incubating with rocking overnight,
10 μ L aliquots of the complex (10 mg Alloderm with ASCs)
were divided into each well of ten 24-well culture plates con-
taining 1 mL DMEM/F-12 media supplemented with 10%
bovine calf serum, and 100 U/mL penicillin-streptomycin.
To induce differentiation, media were replaced with adipo-
genic differentiation media 24 hr after plating, and plates
were incubated for 14 days in an incubator (37℃, 5% CO2).
Differentiation media were changed every 3 days. 
Estimating cell viabilities of ASCs in cultured ASC-
Alloderm complexes
At 1, 4, 7, and 14 days after seeding ASCs in micronized
Alloderm, 200 μ L of sodium 3′ -[1-(phenylamino-carbonyl)-
3,4-tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic
acid hydrate labeling reagent (XTT; Boehringer Mannheim
GmbH, Mannheim, Germany) with electron-coupling rea-
gent were added to each well (described above) and incubat-
ed for 24 hr. The absorbances of media in wells were deter-
mined at 490 nm and 690 nm by spectrophotometry. Cell
viabilities were expressed by calculating the difference bet-
ween ‘the defference between two absorbances of media of
sample in well’ and ‘the difference between two absorbances
of DMEM/F-12 medium containing XTT reagent’.
In vivo implantation of ASC-Alloderm complex
Cultured human ASCs were labeled using PKH67 green
fluorescent cell linker kits (Sigma) to determine whether adi-
pose formation in complexes originated from seeded cells or
from surrounding perivascular tissue. Subsequently, ASCs
were mixed with micronized Alloderm as described above.
ASC-Alloderm complexes were cultured in adipogenic differ-
entiation media for 2 weeks, then 50 mg of ASC-Alloderm
complexes were gently injected subcutaneously into the dor-
sal cranial region of nude male mice using 1 mL syringe with
18 G needle. Among the 8 mice used, 4 mice were injected
with only micronized Alloderm, and 4 mice were injected
with ASC-Alloderm complex. Two months later, the four
mice were sacrificed and the injected tissues were excised.
The excised masses were weighed and then fixed in 10% for-
malin or OCT compound.
Histological examination
ASC-Alloderm complexes were obtained after 14 days of
in vitro culture, and injected tissues were obtained from nude
mice 2 months after implantation. 
For hematoxylin and eosin (H&E) staining, samples were
fixed in 10% formalin, prepared as paraffin blocks, sectioned
at 6 μ m, and stained with H&E.
For Oil-red O staining, injected ASC-Alloderm complexes
excised from nude mice at 2 months after implantation (frozen
in dry ice and stored at -80℃) were placed in a cryomold with
OCT (Tissue-Tek
�, Sakura Finetek Inc., Torrance, CA, U.S.A.).
Ten-micrometer sections were cut using a microtome, placed
on slides, and stained with Oil-red O. Nuclei were then coun-
terstained with hematoxylin, and sections were then cover-
slipped. The slides were examined under a confocal micro-
scope (MRC 1024 MP, Bio-Rad, Hercules, CA, U.S.A.).
Scanning electron microscope (SEM)
ASC-Alloderm complexes obtained after 14 days of in vitro
culture were treated with a fixative containing 3% glutaralde-
hyde and 4% paraformaldehyde in 0.1 M cacodylate buffer
(all pH 7.2) for 1 hr at room temperature. Samples were rinsed
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with 0.1 M cacodylate buffer (3×, 5 min), post-fixed with
1% osmium tetroxide in 0.1 M cacodylate buffer for 2 hr,
dehydrated in ethanol, subjected to critical point drying,
and sputter coated. The samples were examined in a JSM
5410 LV (Jeol LTD, Tokyo, Japan) at 5 kV. 
Statistics
Results are expressed as mean±standard deviation. Sta-
tistical analysis was performed by one-way analysis of vari-
ance (one-way ANOVA) using SPSS Ver. 10 for Windows.
Multiple comparison of Scheffe was used for comparing the
differences for these different culture periods. Differences
were considered significant at p<0.05.
RESULTS
Monolayer culture of ASCs
After ASCs had been cultured as monolayers in differenti-
ation media for 14 days, most were enlarged and contained
many lipid droplets, which were stained by Oil-red O (Fig.
1A), showed a green fluorescence (Fig. 1B).
In vitro culture of ASC-Alloderm complex
ASCs viabilities were; 0.61±0.19, 0.71±0.09, 0.79±
0.15, and 0.86±0.14 after culture for 1, 4, 7, and 14 days
(one-way ANOVA, F=2.939, p=0.065). Although these rates
showed an increasing tendency with culture time (Fig. 2),
no significant difference was observed for these different cul-
ture periods (p>0.05). 
By H&E histological examination, some ASCs in mic-
ronized Alloderm were observed to have differentiated and
to contain large lipid vesicles after 14 days (Fig. 3). 
The micronized Alloderm resembled pieces of dried tree
roots by SEM (Fig. 4A). After culture for 14 days, many cells
were covered the micronized Alloderm, and some spherical
cells suspected of being adipocytes were observed (Fig. 4B).
In vivo implantation of ASC-Alloderm complex
All animals remained healthy throughout the experimen-
Fig. 1. Microscopic findings of adipose stem cells (ASCs) cultured in a monolayer for 14 days. (A) Some ASCs had differentiated into
adipocytes, which contained many lipid droplets as visualized by Oil-red O staining. (B) ASCs were well labeled with PHK67 green fluo-
rescent dye (×400).
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Fig. 2. Changes in ASCs viabilities over 14 days in culture. ASCs
were cultured in vitro after mixing then with micronized Alloderm
(5×10
4 cells/1 mg of Alloderm). Cell viabilities were determined
using XTT colorimetric assays. Values represent mean±stan-
dard deviation (error bar). Tissue Engineering of Injectable Soft Tissue Filler 107
tal period. At two months after implantation, injected tis-
sues were easily identified in the cranial region. The weight
of injected tissues of micronized Alloderm injected group
and ASC-Alloderm complex injected group was 51.4±5.8
mg and 54.6±3.7 mg, respectively, but there was no sig-
nificant difference between the weights of two groups (p>
0.05). An H&E histological examination revealed that some
cells and small capillary had infiltrated the micronized der-
mal matrix in controls (Fig. 5A), whereas markedly increased
numbers of large signet-ring cells and large capillaries were
observed in ASC-Alloderm complex injected mice (Fig. 5B).
Moreover, in injected ASC-Alloderm complexes, signet-ring
cells were stained with Oil-red O and some cells showed weak
green fluorescent under the confocal microscope (Fig. 6).
DISCUSSION
Soft tissue defects range from the furrow of rhytid to a major
loss of subcutaneous tissue secondary to congenital malforma-
tion, trauma, or extirpation. The reconstruction of such de-
fects is the province of plastic surgery. Over the years, various
methods of fat injection or graft have been used, and various
materials evolved to treat such defects. However, these treat-
ment have many limitations, such as donor-site morbidity
and deformity, unsatisfactory and unpredictable results, and
complications resulting from the toxicity of implants (6).
For abrogating these limitations, adipose tissue engineering
recently has been proposed as an alternative for current
treatment (7). The choice of the types of seeding cells and
scaffold used in tissue engineering determines the success of
adipose tissue engineering (7).
The adipose stem cells (ASCs) may be an ideal autologous
cell source for adipose tissue engineering (8). ASCs are much
more resistant to mechanical damage and ischemic conditions
than mature adipocytes (9). Moreover, ASCs can be readily
harvested from excised human subcutaneous fat or liposuc-
tion samples, and proliferate rapidly and differentiate into
mature adipocytes both in vitro and in vivo (4, 10, 11). Many
studies have recently done using ASCs in adipose tissue engi-
neering because ASCs have been demonstrated as a good cell
Fig. 4. Scanning microscopic findings after 14 day of in vitro culture. (A) Micronized Alloderm alone. (B) ASC-Alloderm complex. Many
cells were found to cover the micronized Alloderm, and some spherical adipocyte-like cells were observed.
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Fig. 3. Microscopic findings of in vitro cultured ASC-Alloderm com-
plex for 14 days. ASCs in micronized Alloderm differentiated to
round cells (arrows) with large lipid vesicles (H&E stain, ×400).108 G. Yoo and J.S. Lim
source for adipose tissue engineering because of their high
proliferation, strong differentiation, and less invasive pro-
curement (2, 3). In the present study, as in previous studies,
human ASCs were found to differentiate readily to adipocytes
in monolayer (2-dimensional culture), in 3-dimensional in
vitro cultures, and in vivo.
Alloderm has been used as a good scaffold for skin and oral
mucosa in tissue engineering, and it has been reported to orga-
nize the arrangement of seeded keratinocytes and cultured
keratinocyte sheets into three-dimensional epidermal struc-
ture that has several layers, and to recreate the original rete
ridges at the interface of the dermis (12). The Alloderm has
been found to produce composite oral mucosa equivalent con-
sisting of a stratified epidermis on a dermal matrix using cul-
tured oral keratinocytes and Alloderm (13, 14). In the present
study, micronized Alloderm was used as a scaffold of ASCs
for adipose tissue engineering. In the previous study, a num-
ber of different scaffolds have been investigated for adipose
tissue engineering applications, e.g., polyglycolic acid (PGA)
(10), poly (lactic-co-glycolic acid) (PLGA) (15), and hyaluron-
ic acid (16). In addition, injectable materials, such as, fibrin
(17), matrigel (18), and alginate gel (19) have also been stud-
ied as scaffolds for adipose tissue engineering. Injectable scaf-
folds can widen the scope of the engineered adipose tissue.
This injectable engineered adipose tissue would be easily use-
ful in softening wrinkles, augmenting depressed scars, and
reconstructing nipples. As micronized Alloderm have been
used for soft tissue augmentation of facial rhytids, scars, and
deformities in injectable form (20), micronized Alloderm has
succeeded to this characteristic when they would be used as
a scaffold for adipose tissue engineering. In the present study,
XTT cell viability testing showed that ASCs remained viable
in micronized Alloderm in vitro. Moreover, these adopted a
round morphology and contained large lipid vesicles after 14
days in culture, which suggests that micronized Alloderm is a
suitable ASCs scaffold for adipose tissue engineering purposes. 
Fig. 5. Microscopic findings after 2 months of in vivo implantation. (A) Micronized Alloderm alone. Some fibroblast-like cells and few small
capillaries were observed in the micronized Alloderm. (B) ASC-Alloderm complex. Many signet-ring cells and large capillaries were
found (H&E stain, ×400).
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Fig. 6. Confocal microscopic findings of injected ASC-Alloderm
complexes excised at 2 months after implantation. Many signet-ring
cells were stained by Oil-red O and some cells showed weak green
fluorescence (Oil-red O stain, ×400).
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ASC-Alloderm complexes after 2 months in vivo contained
many signet-ring cells and large capillaries, whereas mic-
ronized Alloderm alone contained some fibroblast-like cells
and few small capillaries. Moreover, many signet-ring cells
in ASC-Alloderm complexes were stained positively by Oil-
red O and also showed green fluorescence indicating that
the observed differentiated adipocytes originated from inject-
ed ASC-Alloderm rather than surrounding fibrovascular tis-
sues. Moreover, implanted ASC-Alloderm complex is softer
than micronized Alloderm alone because of this adipose tis-
sue development. 
In conclusion, the present study suggests that micronized
Alloderm provides a suitable scaffold for ASCs for adipose
tissue engineering purpose, and that ASC-Alloderm complex
has potential as a softer, more natural injectable soft tissue
filler. 
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